-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Hr8Bomfdi0T/Vx4uYjsOxfryZi1etxCciTSD6EU+oGnrh6/bRrrE8iLX15dnTBnU 1TEWAdMT5BBXdU1aCUBZBw== 0001013594-07-000378.txt : 20070806 0001013594-07-000378.hdr.sgml : 20070806 20070806165010 ACCESSION NUMBER: 0001013594-07-000378 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070806 DATE AS OF CHANGE: 20070806 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOENVISION INC CENTRAL INDEX KEY: 0001028205 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113375915 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-78274 FILM NUMBER: 071028422 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 212-750-6700 MAIL ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: ASCOT GROUP INC DATE OF NAME CHANGE: 19961205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ELLIOTT ASSOCIATES, L.P. CENTRAL INDEX KEY: 0000904495 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 222140975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 712 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125062999 MAIL ADDRESS: STREET 1: 712 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ELLIOTT ASSOCIATES LP DATE OF NAME CHANGE: 19930513 SC 13D 1 bioenvision13d-080607.htm AUGUST 6, 2007

 


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)

(Amendment No.)*

Bioenvision, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

09059N100

(CUSIP Number)

Stephen M. Schultz, Esq.

Kleinberg, Kaplan, Wolff & Cohen, P.C.

551 Fifth Avenue, New York, New York 10176

Tel: (212) 986-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

July 25, 2007

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box o.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

 



 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Elliott Associates, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)  

x

 

(b)  

o

3.

SEC USE ONLY

4.

SOURCE OF FUNDS*

WC

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)      o

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.

SOLE VOTING POWER

1,285,225

8

SHARED VOTING POWER

0

9.

SOLE DISPOSITIVE POWER

1,285,225

10.

SHARED DISPOSITIVE POWER

0

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,285,225

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*  

o

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

2.3%

14.

TYPE OF REPORTING PERSON*

PN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Elliott International, L.P.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)  

x

 

(b)  

o

3.

SEC USE ONLY

4.

SOURCE OF FUNDS*

WC

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)      o

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands, British West Indies

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.

SOLE VOTING POWER

0

8

SHARED VOTING POWER

1,927,838

9.

SOLE DISPOSITIVE POWER

0

10.

SHARED DISPOSITIVE POWER

1,927,838

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,927,838

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*  

o

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

3.5%

14.

TYPE OF REPORTING PERSON*

PN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Elliott International Capital Advisors Inc.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)  

x

 

(b)  

o

3.

SEC USE ONLY

4.

SOURCE OF FUNDS*

OO

5.

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)      o

6.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.

SOLE VOTING POWER

0

8

SHARED VOTING POWER

1,927,838

9.

SOLE DISPOSITIVE POWER

0

10.

SHARED DISPOSITIVE POWER

1,927,838

11.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,927,838

12.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)

 

EXCLUDES CERTAIN SHARES*  

o

13.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

3.5%

14.

TYPE OF REPORTING PERSON*

CO

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 



 

 

ITEM 1.

Security and Issuer.

This statement relates to the common stock, $.001 par value (the “Common Stock”), of Bioenvision, Inc. (the “Issuer”). The Issuer’s principal executive office is located at 345 Park Avenue, 41st Floor, New York, New York 10154.

ITEM 2.

Identity and Background.

(a)-(c)     This statement is being filed by Elliott Associates, L.P., a Delaware limited partnership, and its wholly-owned subsidiaries (collectively, “Elliott”), Elliott International, L.P., a Cayman Islands limited partnership (“Elliott International”), and Elliott International Capital Advisors Inc., a Delaware corporation (“EICA” and collectively with Elliott and Elliott International, the “Reporting Persons”). Paul E. Singer (“Singer”), Elliott Capital Advisors, L.P., a Delaware limited partnership (“Capital Advisors”), which is controlled by Singer, and Elliott Special GP, LLC, a Delaware limited liability company (“Special GP”), which is controlled by Singer, are the general partners of Elliott. Hambledon, Inc., a Cayman Islands corporation (“Hambledon”), which is also controlled by Singer, is the sole general partner of Elliott International. EICA is the investment manager for Elliott International. EICA expressly disclaims equitable ownership of and pecuniary interest in any shares of Common Stock.

ELLIOTT

The business address of Elliott is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

The principal business of Elliott is to purchase, sell, trade and invest in securities.

SINGER

Singer’s business address is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

Singer’s principal business is to serve as a general partner of Elliott and Capital Advisors, as the president of EICA, and as a managing member of Special GP.

CAPITAL ADVISORS

The business address of Capital Advisors is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

 

 



 

 

The principal business of Capital Advisors is the furnishing of investment advisory services. Capital Advisors also serves as a managing member of Special GP.

The names, business addresses, and present principal occupation or employment of the general partners of Capital Advisors are as follows:

NAME

ADDRESS

OCCUPATION

Paul E. Singer

712 Fifth Avenue
36th Floor

New York, New York 10019

General partner of Elliott and Capital Advisors; President of EICA; and a managing member of Special GP

 

Braxton Associates, Inc.

712 Fifth Avenue
36th Floor

New York, New York 10019

The principal business of Braxton Associates, Inc. is serving as general partner of

Capital Advisors

 

Elliott Asset Management LLC

712 Fifth Avenue

36th Floor

New York, New York 10019

General Partner of Capital Advisors

 

The name, business address, and present principal occupation or employment of the sole director and executive officer of Braxton Associates, Inc. are as follows:

NAME

ADDRESS

OCCUPATION

Paul E. Singer

712 Fifth Avenue

36th Floor

New York, New York 10019

General partner of Elliott and Capital Advisors and President of EICA

 

ELLIOTT SPECIAL GP, LLC

The business address of Special GP is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

The principal business of Special GP is serving as a general partner of Elliott.

 

 



 

 

The names, business address, and present principal occupation or employment of the managing members of Special GP are as follows:

NAME

ADDRESS

OCCUPATION

Paul E. Singer

712 Fifth Avenue
36th Floor

New York, New York 10019

General partner of Elliott and Capital Advisors; President of EICA; and a managing member of Special GP

 

Braxton Associates, Inc.

712 Fifth Avenue
36th Floor

New York, New York 10019

The principal business of Braxton Associates, Inc. is serving as general partner of

Capital Advisors

 

Elliott Asset Management LLC

712 Fifth Avenue

36th Floor

New York, New York 10019

General Partner of Capital Advisors

 

ELLIOTT INTERNATIONAL

The business address of Elliott International is c/o Maples & Calder, P.O. Box 309, Ugland House, South Church Street, George Town, Cayman Islands, British West Indies.

The principal business of Elliott International is to purchase, sell, trade and invest in securities.

The name, business address, and present principal occupation or employment of the general partner of Elliott International is as follows:

 

 



 

 

NAME

ADDRESS

OCCUPATION

Hambledon, Inc.

c/o Maples & Calder

P.O. Box 309

Ugland House

South Church Street George Town, Cayman Islands

British West Indies

General partner of Elliott International

 

HAMBLEDON

The name, business address, and present principal occupation or employment of the sole director and executive officer of Hambledon are as follows:

NAME

ADDRESS

OCCUPATION

Paul E. Singer

712 Fifth Avenue

36th Floor

New York, New York 10019

General partner of Elliott and Capital Advisors; President of EICA; and a managing member of Special GP

 

EICA

The business address of EICA is 712 Fifth Avenue, 36th Floor, New York, New York 10019.

The principal business of EICA is to act as investment manager for Elliott International.

The name, business address, and present principal occupation or employment of the sole director and executive officer of EICA is as follows:

NAME

ADDRESS

OCCUPATION

Paul E. Singer

712 Fifth Avenue

36th Floor

New York, New York 10019

General partner of Elliott and Capital Advisors; President of EICA; and a managing member of Special GP

 

 

 



 

 

(d) and (e)             During the last five years, none of the persons or entities listed above      has been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

(f)

Mr. Singer is a citizen of the United States of America.

ITEM 3.

Source and Amount of Funds or Other Consideration.

Elliott Working Capital

$7,357,037

Elliott International Working Capital

$11,035,558

ITEM 4.

Purpose of Transaction.

Each of Elliott and Elliott International acquired the Common Stock beneficially owned by it in the ordinary course of its purchasing, selling and trading in securities. EICA has acted as investment manager to Elliott International in connection with Elliott International’s acquisition of beneficial ownership of Common Stock.

Depending upon market conditions and other factors that it may deem material, each of Elliott and Elliott International may purchase additional shares of Common Stock and/or related securities or may dispose of all or a portion of the Common Stock or related securities that it now beneficially owns or may hereafter acquire.

The Reporting Persons reserve the right to discuss and/or meet with management, the Board and other shareholders and/or formulate plans or proposals regarding the Issuer or its securities.

ITEM 5.

Interest in Securities of the Issuer.

(a)           Elliott owns 1,285,225 shares of Common Stock, constituting 2.3% of all of the outstanding shares of Common Stock. Elliott owns its 1,285,225 shares of Common Stock through its wholly owned subsidiary, The Liverpool Limited Partnership, a Bermuda limited partnership.

Elliott International and EICA beneficially own an aggregate of 1,927,838 shares of Common Stock, constituting 3.5% of all of the outstanding shares of Common Stock.

 

 



 

 

Collectively, Elliott, Elliott International and EICA beneficially own 3,213,063 shares of Common Stock constituting 5.8% of all of the outstanding shares of Common Stock.

(b)           Elliott has the sole power to vote or direct the vote of, and to dispose or direct the disposition of, the shares of Common Stock owned by it.

Elliott International has the shared power with EICA to vote or direct the vote of, and to dispose or direct the disposition of, the shares of Common Stock owned by Elliott International. Information regarding each of Elliott International and EICA is set forth in Item 2 of this Schedule 13D and is expressly incorporated by reference herein.

(c)           The transactions effected by the Reporting Persons during the past sixty (60) days are set forth on Schedule 1 attached hereto. No other transactions with respect to the Common Stock that are required to be reported on Schedule 13D were effected by any of the Reporting Persons during the past sixty (60) days.

(d)           No person other than Elliott has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by Elliott.

No person other than Elliott International and EICA has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock beneficially owned by Elliott International and EICA.

 

(e)

Not applicable.

ITEM 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

Not applicable.

ITEM 7.

Material to be Filed as Exhibits.

Exhibit A - Joint Filing Agreement

Schedule 1 – Transactions Effected During the Past 60 Days

 

 



 

 

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, the undersigned each certifies that the information with respect to it set forth in this statement is true, complete and correct.

 

Dated:  

August 6, 2007

 

ELLIOTT ASSOCIATES, L.P.

By:  Elliott Capital Advisors, L.P., as General Partner

 

By:  Braxton Associates, Inc., as General Partner

 

 

 

By:

/s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

ELLIOTT INTERNATIONAL, L.P.

By:  Elliott International Capital Advisors Inc., as Attorney-in-Fact

 

By:

/s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

ELLIOTT INTERNATIONAL CAPITAL ADVISORS INC.

 

 

 

 

By:   /s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

 



 

 

EXHIBIT A

JOINT FILING AGREEMENT

The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Bioenvision, Inc. dated August 6, 2007 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(f) under the Securities Exchange Act of 1934, as amended.

 

Dated:  

August 6, 2007

 

ELLIOTT ASSOCIATES, L.P.

By:  Elliott Capital Advisors, L.P., as General Partner

 

By:  Braxton Associates, Inc., as General Partner

 

 

 

By:

/s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

ELLIOTT INTERNATIONAL, L.P.

By:  Elliott International Capital Advisors Inc., as Attorney-in-Fact

 

By:

/s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

ELLIOTT INTERNATIONAL CAPITAL ADVISORS INC.

 

 

 

 

By:   /s/  Elliot Greenberg

 

Elliot Greenberg

 

Vice President

 

 

 

 



 

 

SCHEDULE 1

Transactions of the Reporting Persons Effected During the Past 60 Days

The following transactions were effected by Elliott Associates, L.P.* during the past sixty (60) days:

 

Date

Security

Amount of Shs. Bought (Sold)

Approx. Price per Share (excl. of commissions)

 

 

 

 

 

02-Aug-2007

Common

10,000

$5.5000

01-Aug-2007

Common

19,898

$5.4981

31-Jul-2007

Common

24,000

$5.5014

30-Jul-2007

Common

32,964

$5.4593

27-Jul-2007

Common

30,000

$5.5380

26-Jul-2007

Common

33,647

$5.5836

25-Jul-2007

Common

52,228

$5.5941

10-Jul-2007

Common

40,000

$5.9743

10-Jul-2007

Common

100,000

$5.9401

10-Jul-2007

Common

40,000

$5.9064

10-Jul-2007

Common

20,000

$5.9099

10-Jul-2007

Common

20,000

$5.8982

10-Jul-2007

Common

20,000

$5.8988

10-Jul-2007

Common

100,000

$5.9361

12-Jun-2007

Common

40,000

$5.5850

11-Jun-2007

Common

81,706

$5.6462

07-Jun-2007

Common

147,327

$5.6865

06-Jun-2007

Common

28,237

$5.7057

05-Jun-2007

Common

445,218

$5.6575

 

*All transactions of Elliott Associates, L.P. were effected through its subsidiary, The Liverpool Limited Partnership, a Bermuda limited partnership.

The following transactions were effected by Elliott International, L.P. during the past sixty (60) days:

 

Date

Security

Amount of Shs. Bought (Sold)

Approx. Price per Share (excl. of commissions)

 

 

 

 

 

02-Aug-2007

Common

15,000

$5.5000

01-Aug-2007

Common

29,847

$5.4981

31-Jul-2007

Common

36,000

$5.5014

30-Jul-2007

Common

49,445

$5.4593

27-Jul-2007

Common

45,000

$5.5380

 

 



 

 

 

26-Jul-2007

Common

50,471

$5.5836

25-Jul-2007

Common

78,342

$5.5941

10-Jul-2007

Common

60,000

$5.9743

10-Jul-2007

Common

150,000

$5.9401

10-Jul-2007

Common

60,000

$5.9064

10-Jul-2007

Common

30,000

$5.9099

10-Jul-2007

Common

30,000

$5.8982

10-Jul-2007

Common

30,000

$5.8988

10-Jul-2007

Common

150,000

$5.9361

12-Jun-2007

Common

60,000

$5.5850

11-Jun-2007

Common

122,560

$5.6462

07-Jun-2007

Common

220,990

$5.6865

06-Jun-2007

Common

42,356

$5.7057

05-Jun-2007

Common

667,827

$5.6575

 

All of the above transactions were effected on the open market.

 

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----